Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective studyJesús García-Donás, Cristina Rodríguez‐Antona, Javier Puente et al.|The Lancet Oncology|2011Cited by 221
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinomaJesús García-Donás, Cristina Rodríguez‐Antona, Luis J. Leandro‐García et al.|Annals of Oncology|2013Cited by 74
Deep sequencing reveals microRNAs predictive of antiangiogenic drug responseJesús García-Donás, Cristina Rodríguez‐Antona, Benoit Beuselinck et al.|JCI Insight|2016Cited by 48
749P Cardiotoxicity in patients treated with PARP-inhibitorsM. Blanco Clemente, C. Maximiano Alonso, M. Martínez Cutillas et al.|Annals of Oncology|2021Cited by 3